TerminatedNot Applicable

Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations

Stopped: The study no longer recruits patients, and its scientific relevance to healthcare practice has become obsolete.

France53 participantsStarted 2017-02-01

Plain-language summary

In previous studies exploring specific sequences of MRI (susceptibility weighted imaging (SWI) and arterial spin labeling (ASL)), the investigators have shown the great sensibility of these MRI sequences to detect arteriovenous shunts, compared to angiography imaging (static or dynamic). This prospective study aims to compare multisequence MRI to brain arteriography imaging in patients undergoing brain arteriovenous malformations embolization.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient ≥ 18 years old * with brain Arteriovenous Malformations * embolization treatment scheduled Exclusion Criteria: * patient's refusal to participate in the study * contraindication to undergo MRI examination * patient under legal protection

What they're measuring

sensitivity of multisequence MRI to detect a residual arteriovenous malformation after embolization

Timeframe: within 3 months after embolization

Trial details

NCT IDNCT02896881

SponsorFondation Ophtalmologique Adolphe de Rothschild

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2025-02-03

View on ClinicalTrials.gov More Brain Arteriovenous Malformations trials